INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
07/01/2019
RNS
Novacyt launches two new CE-IVD Marked molecular diagnostic kits
21/12/2018
Completion of substantial q16 molecular diagnostics order
06/12/2018
06/11/2018
03/10/2018
NOVACYT PARTNERS WITH APPLIED MICROARRAYS IN ASSAY DESIGN
13/09/2018
New research shows a fifth of samples contain unspecified animals’ DNA
05/09/2018
Novacyt Announces Acquisition of Infectious Disease Business from Omega Diagnostics
28/06/2018
Primerdesign’s quality control: The what’s and why’s of ISO certification
15/05/2018
An innovative approach to qPCR multiplexing: A Q+A with Sara Arocas-Torrecillas
23/04/2018
Japanese Encephalitis Virus vaccine was running low, here is what you need to know
25/02/2018
CHIFFRE D’AFFAIRES 2017 DE NOVACYT
24/01/2018
Un réel changement de paradigme avec Primer Design
20/05/2016
Pour toute assistance concernant les relations investisseurs chez Novacyt Group, veuillez cliquer sur le bouton ci-dessous pour contacter notre équipe.
